Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Total Liabilities (2019 - 2026)

Immatics (IMTX) posted Total Liabilities of $654.6 million for Q4 2025, up 7.98% sequentially from $606.2 million in Q3 2025, and down 12.01% YoY from $743.9 million in Q4 2024.

Analysis

Immatics (IMTX) Total Liabilities (2019 - 2026) Analysis & Trends

Immatics has reported Total Liabilities for 7 years, with the latest figure at $654.6 million in Q4 2025.

  • Quarterly Total Liabilities fell 12.01% year-over-year to $654.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $654.6 million (down 12.01% YoY) and the FY2025 annual result came in at $635.3 million, down 15.68% from the prior year.
  • Total Liabilities rose to $654.6 million in Q4 2025 per IMTX's latest filing, from $606.2 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $743.9 million in Q4 2024 and troughed at $193.7 million in Q2 2021.
  • A 5-year average of $391.4 million and a median of $337.0 million in 2022 frame the typical range for Total Liabilities.
  • The sharpest annual moves came in 2024 and 2025: Total Liabilities slumped 54.32% in 2024, then jumped 178.7% in 2025.
  • Over 5 years, Total Liabilities stood at $199.8 million in 2021, then rose by 4.41% to $208.6 million in 2022, then jumped by 50.78% to $314.5 million in 2023, then surged by 136.5% to $743.9 million in 2024, then decreased by 12.01% to $654.6 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods registered $654.6 million, $606.2 million, and $642.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.62 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 4.20 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 1.72 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 4.00 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 10.03 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.35 Bn
10 Immatics 1.17 Bn 711.21 Mn - 555.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 555.40 Mn
Mar 31, 2026 102.40 Mn
Dec 31, 2025 711.87 Mn
Sep 30, 2025 119.10 Mn
Jun 30, 2025 692.25 Mn
Mar 31, 2025 110.54 Mn
Dec 31, 2024 129.62 Mn
Sep 30, 2024 217.52 Mn
Jun 30, 2024 264.59 Mn
Mar 31, 2024 281.36 Mn
Dec 31, 2023 314.55 Mn
Sep 30, 2023 206.50 Mn
Jun 30, 2023 398.24 Mn
Mar 31, 2023 191.49 Mn
Dec 31, 2022 208.61 Mn
Sep 30, 2022 243.25 Mn
Jun 30, 2022 259.68 Mn
Mar 31, 2022 186.53 Mn
Dec 31, 2021 172.26 Mn
Sep 30, 2021 193.11 Mn